Skip to main content
Erschienen in: Skeletal Radiology 8/2023

05.01.2023 | Case Report

Erdheim-Chester disease: diffusion-weighted imaging and dynamic contrast-enhanced MRI provide useful information

verfasst von: Thomas Van Den Berghe, Esther Candries, Nicolas Everaert, Michael Saerens, Jo Van Dorpe, Koenraad Verstraete

Erschienen in: Skeletal Radiology | Ausgabe 8/2023

Einloggen, um Zugang zu erhalten

Abstract

This is, to our knowledge, the first case report with in-depth analysis of bone marrow and bone lesions with diffusion-weighted imaging and dynamic contrast-enhanced MRI in Erdheim-Chester disease to date. We present a case of a 70-year-old woman who was referred for an X-ray of the pelvis, right femur and right knee after complaints of migratory arthralgia in hip and knee five months after an initial hip and knee trauma. Bone lesions on X-ray were identified. This case report highlights the strength and complementary use of modern multimodality multiparametric imaging techniques in the clinical radiological manifestations of Erdheim-Chester disease, in the differential diagnosis and in treatment response assessment, which is classically performed using 18FDG PET-CT. Erdheim-Chester disease is a rare form of non-Langerhans’ cell histiocytosis, mainly affecting individuals in their fifth-seventh decade of life and without sex predominance. Apart from the typical bilateral symmetric lesions in long bone diaphyseal and metaphyseal regions and classically sparing the epiphyses, this multisystemic disease causes significant morbidity by infiltrating critical organs (the central nervous system, cardiovascular system, retroperitoneum, lungs and skin). With non-traumatic bone pain being the most common complaint, Erdheim-Chester disease is diagnosed most often in an incidental setting on imaging. The imaging workup classically consists of a multimodality approach using conventional radiography, CT, MRI, bone scintigraphy and 18FDG PET-CT. This case report extends this evaluation with diffusion-weighted imaging and dynamic contrast-enhanced imaging techniques.
Literatur
1.
2.
3.
Zurück zum Zitat Goyal G, Heaney ML, Collin M, et al. Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood. 2020;135(22):1929–45.CrossRefPubMed Goyal G, Heaney ML, Collin M, et al. Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood. 2020;135(22):1929–45.CrossRefPubMed
4.
Zurück zum Zitat Diamond EL, Dagna L, Hyman DM, et al. Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood. 2014;124(4):483–92.CrossRefPubMedPubMedCentral Diamond EL, Dagna L, Hyman DM, et al. Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood. 2014;124(4):483–92.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Abdelfattah AM, Arnaout K, Tabbara IA. Erdheim-Chester disease: a comprehensive review. Anticancer Res. 2014;34(7):3257–61.PubMed Abdelfattah AM, Arnaout K, Tabbara IA. Erdheim-Chester disease: a comprehensive review. Anticancer Res. 2014;34(7):3257–61.PubMed
6.
Zurück zum Zitat Haroche J, Charlotte F, Arnaud L, et al. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 2012;120(13):2700–3.CrossRefPubMed Haroche J, Charlotte F, Arnaud L, et al. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 2012;120(13):2700–3.CrossRefPubMed
7.
Zurück zum Zitat Dutoit JC, Claus E, Offner F, Noens L, Delanghe J, Verstraete KL. Combined evaluation of conventional MRI, dynamic contrast-enhanced MRI and diffusion weighted imaging for response evaluation of patients with multiple myeloma. Eur J Radiol. 2016;85(2):373–82.CrossRefPubMed Dutoit JC, Claus E, Offner F, Noens L, Delanghe J, Verstraete KL. Combined evaluation of conventional MRI, dynamic contrast-enhanced MRI and diffusion weighted imaging for response evaluation of patients with multiple myeloma. Eur J Radiol. 2016;85(2):373–82.CrossRefPubMed
8.
Zurück zum Zitat Dutoit JC, Verstraete KL. Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma. Skeletal Radiol. 2017;46(6):733–50.CrossRefPubMed Dutoit JC, Verstraete KL. Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma. Skeletal Radiol. 2017;46(6):733–50.CrossRefPubMed
9.
Zurück zum Zitat Van Den Berghe T, Verstraete KL, Lecouvet FE, Lejoly M, Dutoit J. Review of diffusion-weighted imaging and dynamic contrast-enhanced MRI for multiple myeloma and its precursors (monoclonal gammopathy of undetermined significance and smouldering myeloma). Skeletal Radiol. 2022;51(1):101–22.CrossRefPubMed Van Den Berghe T, Verstraete KL, Lecouvet FE, Lejoly M, Dutoit J. Review of diffusion-weighted imaging and dynamic contrast-enhanced MRI for multiple myeloma and its precursors (monoclonal gammopathy of undetermined significance and smouldering myeloma). Skeletal Radiol. 2022;51(1):101–22.CrossRefPubMed
10.
Zurück zum Zitat Joshua DE, Bryant C, Dix C, Gibson J, Ho J. Biology and therapy of multiple myeloma. Med J Aust. 2019;210(8):375–80.CrossRefPubMed Joshua DE, Bryant C, Dix C, Gibson J, Ho J. Biology and therapy of multiple myeloma. Med J Aust. 2019;210(8):375–80.CrossRefPubMed
11.
Zurück zum Zitat Starkebaum G, Hendrie P. Erdheim-Chester disease. Best Pract Res Clin Rheumatol. 2020;34(4):101510.CrossRefPubMed Starkebaum G, Hendrie P. Erdheim-Chester disease. Best Pract Res Clin Rheumatol. 2020;34(4):101510.CrossRefPubMed
12.
Zurück zum Zitat Garg N, Lavi ES. Clinical and neuroimaging manifestations of Erdheim-Chester disease: a review. J Neuroimaging. 2021;31(1):35–44.CrossRefPubMed Garg N, Lavi ES. Clinical and neuroimaging manifestations of Erdheim-Chester disease: a review. J Neuroimaging. 2021;31(1):35–44.CrossRefPubMed
13.
Zurück zum Zitat Cives M, Simone V, Rizzo FM, et al. Erdheim-Chester disease: a systematic review. Crit Rev Oncol Hematol. 2015;95(1):1–11.CrossRefPubMed Cives M, Simone V, Rizzo FM, et al. Erdheim-Chester disease: a systematic review. Crit Rev Oncol Hematol. 2015;95(1):1–11.CrossRefPubMed
14.
Zurück zum Zitat Knitza J, Kampylafka E, Wacker J, Schett G, Manger B. Erdheim-Chester disease: an important differential diagnosis and its main symptoms. Z Rheumatol. 2019;78(1):66–71.CrossRefPubMed Knitza J, Kampylafka E, Wacker J, Schett G, Manger B. Erdheim-Chester disease: an important differential diagnosis and its main symptoms. Z Rheumatol. 2019;78(1):66–71.CrossRefPubMed
15.
Zurück zum Zitat Campochiaro C, Tomelleri A, Cavalli G, Berti A, Dagna L. Erdheim-Chester disease. Eur J Intern Med. 2015;26(4):223–9.CrossRefPubMed Campochiaro C, Tomelleri A, Cavalli G, Berti A, Dagna L. Erdheim-Chester disease. Eur J Intern Med. 2015;26(4):223–9.CrossRefPubMed
16.
Zurück zum Zitat Munoz J, Janku F, Cohen PR, Kurzrock R. Erdheim-Chester disease: characteristics and management. Mayo Clin Proc. 2014;89(7):985–96.CrossRefPubMed Munoz J, Janku F, Cohen PR, Kurzrock R. Erdheim-Chester disease: characteristics and management. Mayo Clin Proc. 2014;89(7):985–96.CrossRefPubMed
17.
Zurück zum Zitat Antunes C, Graça B, Donato P. Thoracic, abdominal and musculoskeletal involvement in Erdheim-Chester disease: CT, MR and PET imaging findings. Insights Imaging. 2014;5(4):473–82.CrossRefPubMedPubMedCentral Antunes C, Graça B, Donato P. Thoracic, abdominal and musculoskeletal involvement in Erdheim-Chester disease: CT, MR and PET imaging findings. Insights Imaging. 2014;5(4):473–82.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Haroche J, Papo M, Cohen-Aubart F, et al. Erdheim-Chester disease (ECD), an inflammatory myeloid neoplasia. Presse Med. 2017;46(1):96–106.CrossRefPubMed Haroche J, Papo M, Cohen-Aubart F, et al. Erdheim-Chester disease (ECD), an inflammatory myeloid neoplasia. Presse Med. 2017;46(1):96–106.CrossRefPubMed
19.
Zurück zum Zitat Choraria A, Andrei V, Rajakulasingam R, Saifuddin A. Musculoskeletal imaging features of non-Langerhans cell histiocytoses. Skeletal Radiol. 2021;50(10):1921–40.CrossRefPubMed Choraria A, Andrei V, Rajakulasingam R, Saifuddin A. Musculoskeletal imaging features of non-Langerhans cell histiocytoses. Skeletal Radiol. 2021;50(10):1921–40.CrossRefPubMed
20.
Zurück zum Zitat Wang F, Cao X, Niu N, et al. Multisystemic imaging findings in Chinese patients with Erdheim-Chester disease. AJR Am J Roentgenol. 2019;213(6):1179–86.CrossRefPubMed Wang F, Cao X, Niu N, et al. Multisystemic imaging findings in Chinese patients with Erdheim-Chester disease. AJR Am J Roentgenol. 2019;213(6):1179–86.CrossRefPubMed
21.
Zurück zum Zitat Kumar P, Singh A, Gamanagatti S, Kumar S, Chandrashekhara SH. Imaging findings in Erdheim-Chester disease: what every radiologist needs to know. Pol J Radiol. 2018;83:e54–62.CrossRefPubMedPubMedCentral Kumar P, Singh A, Gamanagatti S, Kumar S, Chandrashekhara SH. Imaging findings in Erdheim-Chester disease: what every radiologist needs to know. Pol J Radiol. 2018;83:e54–62.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Moulis G, Sailler L, Bonneville F, Wagner T. Imaging in Erdheim-Chester disease: classic features and new insights. Clin Exp Rheumatol. 2014;32(3):410–4.PubMed Moulis G, Sailler L, Bonneville F, Wagner T. Imaging in Erdheim-Chester disease: classic features and new insights. Clin Exp Rheumatol. 2014;32(3):410–4.PubMed
Metadaten
Titel
Erdheim-Chester disease: diffusion-weighted imaging and dynamic contrast-enhanced MRI provide useful information
verfasst von
Thomas Van Den Berghe
Esther Candries
Nicolas Everaert
Michael Saerens
Jo Van Dorpe
Koenraad Verstraete
Publikationsdatum
05.01.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Skeletal Radiology / Ausgabe 8/2023
Print ISSN: 0364-2348
Elektronische ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-022-04265-5

Weitere Artikel der Ausgabe 8/2023

Skeletal Radiology 8/2023 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.